Using brain stimulation to reduce fatigue after a stroke
Official title: Home-based Post-stroke Fatigue Treatment Using Transcranial Direct Current Stimulation (tDCS)
Run by Weill Medical College of Cornell University · NCT05816603 · Data updated 2026-11-12
This study is testing whether a brain stimulation treatment can help reduce fatigue in people who have had a stroke.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | May 23, 2023 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT05816603 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 who are more than three months post-stroke and experience severe fatigue.
✕Probably not a fit
Patients with a history of seizures, severe depression, or significant cognitive impairment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of transcranial direct current stimulation (tDCS) as a non-drug treatment for post-stroke fatigue. It involves a double-blind, sham-controlled, randomized design with 24 participants, where half will receive real stimulation and the other half will receive a placebo. The tDCS device will be applied daily for 20 minutes over a two-week period, with follow-up assessments to evaluate fatigue severity and neuroimaging to observe brain changes. The goal is to determine if this intervention can effectively reduce fatigue in stroke survivors.
Why it matters
Potential benefit: If successful, this approach could significantly alleviate fatigue in stroke survivors, improving their quality of life.
How similar studies have gone: Other studies using tDCS for various neurological conditions have shown promising results, suggesting potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female patients aged \>18 years * Greater than 3 months from first hemorrhagic or ischemic stroke (subacute to chronic), confirmed through neuroimaging (CT or MRI). * Fatigue severity score average \>4 (severe fatigue) * Willingness to remain stable on pharmacologic therapy through the duration of the study. * Availability of a caregiver, family member, or friend to be present during the administration of the tDCS intervention. Exclusion Criteria: * Metal in the head (except mouth) or implanted cranial or thoracic devices (i.e. pacemaker, DBS stimulator) * History of seizure * History of moderate to severe traumatic brain injury * A score of 10 or more on the PHQ-9 or GAD-7 scale, suggestive of moderate to severe depression/anxiety. * A score of less than 21 on the MoCA suggesting major neurocognitive disorder. * Signs of skin rash, infection, or laceration in the supraorbital region where the tDCS will be applied. * Inability to provide informed consent * Other major neurological, medical, or psychiatric illnesses that could confound results in the opinion of the site investigator.
Where it's running
-
Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Joan M Stilling, MD, MS — Weill Medical College of Cornell University
- Study coordinator: Zhiyan Yang, M.A.
- Email: rehabresearch@med.cornell.edu
- Phone: (212) 746-1509
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Micro-choice-based approach to fatigue management
A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.
-
HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults
This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.
-
See if Nuvastatic helps with cancer-related fatigue in colon cancer patients on first-line chemotherapy
This trial tests whether Nuvastatic can lessen fatigue in adults with colon cancer who are receiving their first round of chemotherapy, compared to placebo.
-
Balance and gait in multiple sclerosis: linking motion data to function
Researchers will see if precise motion measurements of balance and walking relate to everyday functional tests in adults with MS.
-
Relaxation and breathing techniques to help with breathlessness and tiredness in cancer patients in palliative care
This study tests whether progressive muscle relaxation or deep breathing exercises can reduce dyspnea and fatigue and improve self-care in adults with cancer receiving palliative care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.